Neurocentrx
Developer of oral delivery medicines designed to treat patients with neurological conditions. The company's medicines are oral ketamine formulations that treat central nervous system conditions and ca...
Valuation
$0
Share Price
N/A
Total Raised
$6.2M
Last Round
N/A